SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Bio Technology General - BTGC -- Ignore unavailable to you. Want to Upgrade?

To: Jim Oravetz who wrote (2012)7/21/2000 3:05:20 PM
From: Jim Oravetz  Read Replies (1) | Respond to of 2028
 
"Contract fees in the three and six months ended June 30, 2000 were $7.5 million and $10.0 million, respectively, significant increases over contract fees of $1.7 million and $4.6 million, respectively, in the comparable 1999 periods."

Another Q saved by rather LARGE TEVA contract fees. Only 7% increase in Oxandrin.

Annual Meeting: Sept. 5th, 2000

Jim


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News